Lv1
68 积分 2023-10-16 加入
The fecal mycobiome in non-alcoholic fatty liver disease
1天前
待确认
T cell–mediated regulation of the microbiota protects against obesity
1天前
已完结
Hydrogen sulfide produced by the gut microbiota impairs host metabolism via reducing GLP-1 levels in male mice
8天前
已完结
Characterization by HPLC–ESI–MS2 of native and oxidized procyanidins from litchi (Litchi chinensis) pericarp
19天前
已完结
Identification of the major flavonoids from pericarp tissues of lychee fruit in relation to their antioxidant activities
19天前
已完结
NAFLD and NASH: etiology, targets and emerging therapies
19天前
已完结
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
19天前
已完结
Treatment Candidacy for Pharmacologic Therapies for NASH
19天前
已完结
Steatotic liver disease
19天前
已完结
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
19天前
已完结
皖公网安备34019202002308
